Proton pump inhibitors significantly increase the intracellular concentration of nilotinib, but not imatinib in target CML cells

White, D.Eadie, L.Saunders, V.Hiwase, D.Hughes, T.2013-07-232013-07-232013Leukemia, 2013; 27(5):1201-12040887-69241476-5551http://hdl.handle.net/2440/78906en© 2013 Macmillan Publishers LimitedK562 CellsHumansBenzamidesPiperazinesPyrimidinesProtein Kinase InhibitorsDrug InteractionsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveProton Pump InhibitorsImatinib MesylateProton pump inhibitors significantly increase the intracellular concentration of nilotinib, but not imatinib in target CML cellsJournal article002012878210.1038/leu.2012.2950003186983000312-s2.0-8487762230519292White, D. [0000-0003-4844-333X]Eadie, L. [0000-0003-1912-7602]Hiwase, D. [0000-0002-6666-3056]Hughes, T. [0000-0002-0910-3730] [0000-0002-7990-4509]